Summary. Blood flow in the corpus luteum of the pseudopregnant rabbit was measured with tracer-labelled microspheres before and at 1 and 3 h after saline treatment (N = 8) or after inhibition of progesterone synthesis with aminoglutethimide (N = 10). Before treatment luteal blood flow (29\m=.\5 \m=+-\3\m=.\9 ml /mi n\m=.\g\m=-\1 (mean \ m=+-\s.e.m.)) was much higher than blood flow to other tissues (ovarian stroma = 2\m=.\9\ m=+-\ 0\m=.\6; uterus = 0\m=.\5\ m=+-\0\m=.\1; adrenal gland = 2\m=.\6 \ m=+-\ 0\m=.\2 ml / mi n\ m=. \ g\ m=-\ 1) . Aminoglutethimide reduced serum progesterone by 60% within 1 h but luteal blood flow was unchanged (26\m=.\2 \m=+-\3\m=.\5 ml /mi n\m=.\g\m=-\1). At 3 h after aminoglutethimide, serum progesterone remained low and luteal blood flow was slightly reduced to 22\m=.\5\m=+-\3\m=.\4 ml /mi n\m=.\g\m=-\1. This reduction was associated with a significant decline in mean arterial blood pressure which resulted in luteal vascular resistance being unaltered by aminoglutethimide treatment. Further analysis of these data indicated that serum progesterone concentration was not significantly correlated with blood flow to the corpora lutea or with blood flow to other tissues. In contrast, mean arterial blood pressure was highly correlated with blood flow to the corpus luteum (r = 0\m=.\80; P < 0\m=.\001) but not to the ovarian stroma (r = 0\m=.\04), or adrenal gland (r = 0\m=.\06). These results indicate that luteal blood flow is not acutely responsive to changes in luteal progesterone production and suggest that luteal blood flow changes passively with changes in arterial blood pressure.
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Introduction
The mammalian corpus luteum has one of the highest rates of blood flow of any tissue or organ (Abdul-Karim & Bruce, 1973; Janson & Albrecht, 1975; Devoto et ai, 1977; Ford et ai, 1982) , but the physiological regulation of luteal blood flow is not well understood. Because the corpus luteum produces progesterone, the hypothesis has developed that progesterone, at high concentrations, might be responsible for maintaining low vascular resistance in the corpus luteum (Ellinwood et ai, 1978) . Serum progesterone is positively correlated to the rate of blood flow in the ovary containing luteal tissue (Niswender et ai, 1975; Ford et ai, 1979; Ford & Chenault, 1981; Janson et ai, 1981; Magness et ai, 1983) , and progesterone treatment increases ovarian blood flow in pregnant rats (Waddell et ai, 1982) . These observations are consistent with the hypothesis that progesterone leads to dilatation of the ovarian and perhaps the luteal vasculature. To test this hypothesis directly, we determined the acute effect of inhibiting progesterone synthesis on blood flow and vascular resistance in the corpus luteum, while simultaneously maintaining the serum concentration of the luteotrophic hormone, oestradiol-17ß (Keyes & Nalbandov, 1967; Bill & Keyes, 1983 (Holt et ai, 1975) .
Radioimmunoassay. Serum progesterone concentration was measured by radioimmunoassay using a procedure developed by Niswender (1973) , and modified for measurement in rabbit serum (Holt et ai, 1975 (model 351) , at a continuous rate of 20 ml/min. Approximately 300000 microspheres in 3ml warmed saline (0-9% (w/v) NaCl) were infused into the left ventricle over 15 sec. The syringe and infusion catheter were then flushed twice with 3 ml warm saline to remove residual microspheres. The withdrawal of the reference sample was continued for 1 min after the first saline flush and this reference blood sample was dried in scintillation vials in a desiccator oven at 65°C. Second and third blood flow measurements were performed as described above utilizing microspheres labelled with a different radioisotope for each measurement. At the end of the experiment, animals were killed by intraventricular injection of concentrated RC1 and the ovaries, uterus, vagina, adrenal glands, and kidneys were removed. The corpora lutea were carefully dissected from the rest of the ovarian tissue and all tissues were stored in 10% formalin. = mean arterial pressure/tissue blood flow. General experimentalprotocol. On Day 9 of pseudopregnancy, rabbits were anaesthetized and an initial blood flow measurement was performed as described above. A blood sample was then obtained from the abdominal aorta for the determination of pretreatment serum progesterone concentration. The animals were then treated with one of the following: (1) an injection of 300 mg aminoglutethimide phosphate/kg body weight (Ciba-Geigy, Summit, NJ) in 10 ml saline (N = 5); (2) an injection of 10 ml saline (N = 4); (3) an injection of 300 mg aminoglutethimide phosphate/ kg followed by an infusion of 150 mg aminoglutethimide phosphate/kg-h" ' for 3 h (N = 5); (4) a saline injection and subsequent saline infusion (N = 4). Subsequent blood flow determinations were performed and blood samples were taken at 1 and 3 h after the start of treatment in all animals.
Statistics. All statistical analyses were performed using the Statview 512+ statistics program for the Macintosh microcomputer. Differences between groups of animals were analysed by a repeated measures analysis of variance; within-animal changes in blood flow and vascular resistance during the aminoglutethimide or saline treatments were analysed by analysis variance followed by Scheffe's Fl test. The correlation coefficients (Ott, 1977) were calculated for the natural log of the tissue blood flow versus the natural log of serum progesterone concentration or mean arterial pressure.
Results

Reliability of blood flow measurements
To document that the blood flow estimates in the corpora lutea were accurate, the number of microspheres trapped in the tissue was determined. The total luteal tissue from each animal received~24 000 microspheres, which corresponds to less than a 5% error in blood flow value due to random variability in microsphere distribution (Buckberg et ai, 1971) . The difference in blood flow between the right and left kidneys was used as an index of adequate microsphere mixing (Heymann et ai, 1977 Since blood flows and other measures were the same in animals treated by injection or infusion of saline, the data were pooled. Saline treatment had no significant effect on mean arterial pressure or blood flow to the corpus luteum, which remained at high levels at 1 and 3 h (Table 1 ). Significant changes were observed in ovarian blood flow at 1 h of saline administration, and in kidney blood flow at 3 h (Table 1) . Blood flow and other measures were the same in animals treated by injection or infusion of aminoglutethimide and, therefore, the data were pooled. Aminoglutethimide treatment was accompanied by small, but significant, reductions in mean arterial pressures (Table 1) . At 1 h there was no significant change in blood flow to the corpus luteum, but at 3 h the decreased mean arterial blood pressure was associated with a significant reduction in blood flow to the corpus luteum as well as to the vagina and kidneys (Table 1 ). Despite the diminution of blood flow to these organs, vascular resistance, which is the critical measure of vascular control, was unchanged and was not different from that in saline-treated animals (Fig. 1) . Progesterone production was therefore reduced with aminoglutethimide, but this was not associated with significant alteration in vascular resistance of the corpus luteum. The low vascular resistance in the corpus luteum, relative to that in other tissues (Fig. 1) , was reflected in the high rate of luteal blood flow which was 10-fold greater than ovarian stromal blood flow, 50-fold greater than uterine blood flow, 75-fold greater than vaginal blood flow, 10-fold greater than adrenal gland blood flow, and 4-fold greater than kidney blood flow (Table 1) . Bruce, 1973; Janson & Albrecht, 1975; Devoto et ai, 1977) , and confirmed here, the corpus luteum has a very high rate of blood flow. This high rate of blood flow suggests that the blood vessels of the corpus luteum exert a low resistance to blood flow.
The objective of this study was to determine whether progesterone or other steroids might be responsible for maintaining a low vascular resistance in the corpus luteum. Progesterone has been shown to cause changes that are consistent with a role as a vasodilator: progesterone treatment increases ovarian blood flow in pregnant rats (Waddell et ai, 1982) ; progesterone decreases the contractile activity of myometrial (Allen & Reynolds, 1935) and gastrointestinal (Gill et ai, 1985) smooth muscle; progesterone pellets placed in the uterine horn cause an increase in the diameter of the ovarian and uterine vein in ovariectomized mice (Forbes & Glassen, 1972) ; and progesterone modifies the responsiveness of blood vessels to vasoactive agents (Orosz et ai, 1983; Skoog & Kenney, 1983) . The inhibition of progesterone production by aminoglutethimide, however, did not change vascular resistance within the corpus luteum. The slight fall in luteal blood flow during aminoglutethimide treatment (Table 1) cannot be attributed to a direct effect of amino¬ glutethimide within the corpus luteum, because of the concomitant decline in mean arterial pressure in this group. Blood flow to the corpus luteum correlates closely with alterations in mean arterial pressure ( Table 2 ), suggesting that the corpus luteum is operating on a linear pressure-flow curve.
Aminoglutethimide inhibits steroidogenesis by competing with cholesterol for the binding site on the mitochondrial P-450 enzyme that is responsible for cleaving the cholesterol side-chain (Uzgiris et ai, 1977; Simpson, 1979) . Our results indicate that aminoglutethimide caused a 60% reduction in peripheral serum concentrations of progesterone within 1 h, and that this reduction was still present at 3h. This interval was chosen as a reasonable period to expect a change in vascular resistance since oestradiol-17ß causes vasodilatation of the uterine vasculature within 30 min and has maximal effects by 2-3 h (for review see Meschia, 1983) . Despite a marked decline in luteal progesterone production, the vascular resistance within the corpus luteum was not altered by the aminoglutethimide treatment. This finding leads to our main conclusion that vascular resist¬ ance in the corpus luteum is not acutely dependent upon the normal rates of luteal progesterone production at this stage of pseudopregnancy.
In other studies, serum progesterone concentration, and luteal or ovarian blood flow were significantly correlated (Niswender et ai, 1975 (Niswender et ai, , 1976 Ford et ai, 1979; Ford & Chenault, 1981; Janson et ai, 1981; Magness et ai, 1983) , an observation that at first glance seems contradictory to the results reported here. However, these correlations were made throughout the entire luteal phase and include the effects of marked structural changes that occur in the luteal vasculature. The luteal vasculature is formed initially by multiplication and invasion of the thecal capillaries (for review see Findlay, 1986) , leading to increased blood flow in the developing corpus luteum, which also has increased steroidogenic capacity. At the end of the luteal phase, in most species, luteal blood flow declines as serum progesterone values fall (Bruce & Moor, 1976; Niswender et ai, 1976; Devoto et 1983 ). Again this change in luteal blood flow is associated with structural changes in the vasculature, since the number of luteal endothelial cells declines during luteolysis (Niswender et ai, 1976; Azmi et ai, 1984; Farin et ai, 1986) . Therefore, the lack of a correlation between serum progesterone concentration and luteal blood flow, in our experiments and in experiments of others (Bruce et ai, 1980; Bruce & Meyer, 1981) (Keyes & Nalbandov, 1967; Bill & Keyes, 1983) and has been shown to increase ovarian blood flow in sheep (Rosenfeld, 1980) . In the present experiments, oestradiol was administered continuously in order to ensure that any observed changes in blood flow were not attributable to diminished availability of oestrogen. In a separate study (Wiltbank, 1987) (Ott, 1977) , 65% of the variation in blood flow to the corpus luteum can be explained by variation in mean arterial pressure, whereas in other tissues, < 40% of the variation is attribu¬ table to changes in mean arterial pressure. Other investigators have also reported a positive correlation between mean arterial pressure and luteal blood flow in anaesthetized rabbits (Janson & Albrecht, 1975; Janson et ai, 1981) and rats (Selstam et ai, 1985) . At variance with the above, is a report by Bruce & Gibbs (1976) who observed a negative correlation between mean arterial pressure and luteal blood flow (r = -0-425) in unanaesthetized pregnant rabbits. However, these investigators observed that the unanaesthetized rabbits "were hyperventilating ... [possibly] due to anxiety and disturbance of their catecholamine levels" (Bruce & Gibbs, 1976 ). An elevation in catecholamine concentrations could change the relationship between mean arterial pressure and luteal blood flow: catecholamines may increase mean arterial pressure but potentially decrease luteal blood flow (Selstam et ai, 1985 ; M. C. Wiltbank, K. P. Gallagher & P. L. Keyes, unpublished results).
In conclusion, the lack of responsiveness of the luteal vasculature to changes in hormonal milieu, and the positive correlation between blood flow and mean arterial pressure, suggest that the luteal vascular system is operating on a linear pressure-flow curve with a very low vascular resistance. The basis of low vascular resistance appears to be related to structural elements in the corpus luteum, such as high capillary density and lack of muscular arterioles (Dharmarajan et ai, 1985; Wiltbank, 1987) rather than to hormonal factors. This view is consistent with our knowledge of the luteal vasculature, which appears to consist of sinusoidal capillaries (Sobotta, 1897; Dharmarajan et ai, 1985) , and which lacks autonomie nerves (Burden, 1972; Unsicker, 1974) or vascular smooth muscle (Wiltbank, 1987) . This work was supported by NIH grants HD-07127 (P.L.K.), P30-HD-18258, HL-32043 (K.P.G.), NIH Training Grant HD-07048 (M.C.W.), and NIH Career Development Award HL-04120(K.P.G.).
